Notifications
Back

Company

Let me introduce the KOREAVACCINE

History

2025

05
Achieved ISO 45001 certification 
03
Achieved ISO 37001 certification 

2024

07
Filed for the installation and operation of the BL2 Research facility
05
Established the Seoul Research Institute

2023

08Constructed a new BIOPLANT building

2022

12
Constructed a staff lounge at Ansan Plant
09
Achieved ISO 45001 certification(KOREAVACCINESALES)
04
Achieved ISO 37001 certification(KOREAVACCINESALES) 
02
Sung Bae Ha was inaugurated as the representative director of KOREAVACCINE

2021

11Conducted a launch ceremony for ISO 37001 auditor (KOREAVACCINESALES)

2019

08Sung Bae Ha was inaugurated as the President of KOREAVACCINESALES CO., LTD.
07
Constructed assembly room for syringes and clean room at Ansan Plant
04
Obtained the approval of KOVAX Safety Syringe

2017

09Received MSD’s GMP inspection

2016

10Received overseas GMP inspection from the Colombian government
05
Built a cafeteria at Ansan Plant

2015

09Received overseas GMP inspection from the Argentina government

2013

11Expanded New Cold Storage Building at Ansan
07Authorized GMP compliance for the production of freeze-dried vials by the Colombian Government
06Set for IL-YANG PHARM’s influenza vaccine distribution strategy
04- Granted Smart Hub Environmental Certification for Ansan Plant
- Signed a contract for the consignment production of the influenza vaccine with IL-YANG PHARM

2012

09Signed a distribution agreement with Novatis Korea Ltd. for VAXEMHIB
06
Signed a distribution contract with Novatis Korea Ltd. for Menveo

2011

07Signed a distribution contract with Novatis Korea Ltd. for Agrippal

2010

08KOREAVACCINESALES was separated from KOREAVACCINE CO.,LTD.

2009

06Chairman Chang-hwa Ha received a Civil Merit Medal on the 2nd Medical Device’s Day

2008

04Acquired an approval of Freeze-dried BCG vaccine for Percutaneous Use(Japan Strain)

2007

09Received authorization from KFDA for prefilled syringe production in the new GMP Facility at Ansan
02
Signed a supply & distribution agreement with Sanofi Pasteur for pediatric vaccines 
01
Implemented the logistics validation system for the first time in the industry

2006

09Conducted a completion ceremony of the Ansan Plant
04
Received authorization from KFDA for vial manufacturing in the new GMP Facility at Ansan
03
Chairman Chang-Wha Ha was awarded The Minister of Finance & Economy on the 40th Taxpayer’s Day.

2005

12Finished building the new GMP factory according to global standards

2002

05Obtained CE mark for medical device product

2001

12Obtained KGSP(Korea Good Supply Practice) certification

1997

12Obtained ISO-9002 certification for medical device product

1996

07
Following the merger with Dae-A Corporation, KOREAVACCINE Company modified its name to KOREAVACCINE CO., LTD.

1993

12
Obtained KGMP certification for Ansan Plant from KFDA

1991

04
Completed construction of the GMP Facility at Ansan(Ansan Plant) 

1982

05
Registered the trademark “KOVAX” in the Korean Intellectual Property Office

1976

01
Chang-Wha Ha was Inaugurated as President 

1972

09
Acquired a patent for a technique to stabilize the polio vaccine
08
Acquired pharmaceutical manufacturing license

1971

12
Acquired a hygiene device manufacturing license

1968

02
Acquired a medical device manufacturing license

1956

01
Established as KOREAVACCINE Company


Privacy Policy　


Trade name : Korea Vaccine Co., Ltd  |  Business Number : 134-81-27112  

Korea Vaccine Co., Ltd  : 128 Moknae-ro, Danwon-gu, Ansan-si, Gyeonggi-do  / TEL : 031-495-6397(BIO PLANT) / 031-492-6614(MEDICAL PLANT) 

Korea Vaccine Sales Co., Ltd  : 4F 10, Macheon-ro 5-gil, Seoul, Republic of Korea / TEL : 02-443-1961 

Korea Vaccine Trading Co., Ltd  : 4F 10, Macheon-ro 5-gil, Seoul, Republic of Korea / TEL : 02-2249-1961 



COPYRIGHT ⓒ Korea Vaccine Co., Ltd ALL RIGHT RESERVED.